BELLUS Health Inc. (BLU)
NASDAQ: BLU
· Real-Time Price · USD
14.74
0.00 (0.00%)
At close: Jun 28, 2023, 9:59 PM
BELLUS Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.17B | 1.52B | 15K | 16K | 16K | 16K | 16K | 16K | 16K | 15K | 15K |
Cost of Revenue | 5.41B | 4.72B | 3.28B | 1.84B | 923.92M | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -2.23B | -3.2B | -3.28B | -1.84B | -923.91M | 16K | 16K | 16K | 16K | 15K | 15K |
Operating Income | -155.42M | -111.98M | -90.31M | -77.88M | -72.71M | -72.5M | -72.67M | -73.28M | -64.88M | -48.26M | -39.59M |
Interest Income | 10M | 9.62M | 7.92M | 5.08M | 2.61M | 795K | 458K | 233K | 277K | 480K | 733K |
Pretax Income | -105.21M | -88.83M | -86.73M | -76.02M | -72.76M | -70.91M | -70M | -71.42M | -63.95M | -46.78M | -37.38M |
Net Income | -108.19M | -90.2M | -86.79M | -76.08M | -72.6M | -70.77M | -69.83M | -71.22M | -63.95M | -46.78M | -37.38M |
Selling & General & Admin | 218.28M | 123.42M | 20.84M | 19.5M | 19.43M | 17.42M | 14.84M | 14.26M | 13.17M | 9.81M | 10.44M |
Research & Development | 39.97M | 57.32M | 69.92M | 58.89M | 53.88M | 55.79M | 58.59M | 59.79M | 52.47M | 39.14M | 29.74M |
Other Expenses | -185K | -298K | -438K | -491K | -379K | -266K | -126K | n/a | n/a | n/a | n/a |
Operating Expenses | 224.16M | 166.97M | 90.32M | 77.9M | 72.72M | 72.52M | 72.69M | 73.3M | 64.89M | 48.27M | 39.6M |
Interest Expense | 43K | 69K | 84K | 78K | 66K | 50K | 43K | 55K | 59K | 56K | 56K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.28B | 1.61B | 90.32M | 77.9M | 72.72M | 72.52M | 72.69M | 73.3M | 64.89M | 48.27M | 39.6M |
Income Tax Expense | 3.1M | 1.43M | 54K | 60K | -147K | -112K | -145K | -144K | 59K | 56K | 56K |
Shares Outstanding (Basic) | 392.95M | 410.34M | 126.58M | 115.36M | 121.8M | 106.76M | 106.49M | 78.83M | 78.34M | 78.34M | 78.34M |
Shares Outstanding (Diluted) | 405.79M | 410.34M | 126.58M | 115.36M | 121.8M | 106.76M | 106.49M | 78.83M | 78.34M | 78.34M | 78.34M |
EPS (Basic) | -0.52 | -0.61 | -0.74 | -0.67 | -0.7 | -0.79 | -0.84 | -0.91 | -0.85 | -0.65 | -0.56 |
EPS (Diluted) | -0.52 | -0.61 | -0.74 | -0.67 | -0.7 | -0.79 | -0.84 | -0.91 | -0.85 | -0.65 | -0.56 |
EBITDA | -135.57M | -97.41M | -82.57M | -72.76M | -70.09M | -71.73M | -72.26M | -72.86M | -64.42M | -47.59M | -38.68M |
EBIT | -149.24M | -107.43M | -86.65M | -75.94M | -72.73M | -70.93M | -70.09M | -71.55M | -64.11M | -47.15M | -38M |
Depreciation & Amortization | 19.85M | 14.57M | 7.74M | 5.12M | 2.56M | 674K | 248K | 193K | 181K | 181K | 179K |